Saturable small intestinal drug absorption in humans: Modeling and interpretation of cefatrizine data

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 45, Issue 2, 1998, Pages 199-203

  Yu, Lawrence X ^a   Amidon, Gordon L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cefatrizine; Compartmental absorption and transit model; Fraction of dose absorbed; Passive absorption; Pharmacokinetic modeling; Saturable absorption

Indexed keywords

CEFATRIZINE;

ARTICLE; COMPUTER SIMULATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DEGRADATION; GASTROINTESTINAL TRANSIT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MODEL; ORAL DRUG ADMINISTRATION; SMALL INTESTINE ABSORPTION;

CEFATRIZINE; CEPHALOSPORINS; HUMANS; INTESTINAL ABSORPTION; INTESTINE, SMALL; MODELS, BIOLOGICAL;

EID: 0031982148     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00088-X     Document Type: Article

References (23)

1. Nakashima E., Tsuji A., Kagatani S., Yamana T. Intestinal absorption mechanism of amino-β-lactam antibiotics. III. Kinetics of carrier-mediated transport across the rat small intestine in situ. J. Pharm. Dyn. 7:1984;452-464.
2. A. Tsuji, Intestinal absorption of β-lactam antibiotics, in: M.D. Taylor, G.L. Amidon (Eds.), Peptide-Based Drug Design, ACS Professional Reference Book, American Chemical Society, Washington, DC, 1995, pp. 101-134.
3. Sinko P.J., Amidon G.L. Characterization of the oral absorption of β-lactam antibiotics. I. Cephalosporins: determination of intrinsic membrane absorption parameters in the rat intestine in situ. Pharm. Res. 5:1988;645-650.
4. Sinko P.J., Amidon G.L. Characterization of the oral absorption of β-lactam antibiotics. II. Competitive absorption and peptide carrier specificity. J. Pharm. Sci. 78:1989;723-727.
5. Sjovall J., Alvan A., Westerlund D. Dose-dependent absorption of amoxycillin and bacampicillin. Clin. Pharmacol. Ther. 38:1985;241-250.
6. Barr W.H., Zola E.M., Candler E.L., Hwang S.-M., Tendolkar A.V., Shamburek R., Parker B., Hilty M.D. Differential absorption of amoxicillin from the human small and large intestine. Clin. Pharmacol. Ther. 56:1994;279-285.
7. Reigner B.G., Couet W., Guedes J.-P., Fourtilla J.B., Tozer T.N. Saturable rate of cefatrizine absorption after oral administration to humans. J. Pharmacokinet. Biopharm. 18:1990;17-34.
8. Piotrovskij V.K., Paintaud G., Alvan G., Trnovec T. Modeling of the saturable time-constrained amoxicillin absorption in humans. Pharm. Res. 9:1994;1346-1351.
9. Yu L.X., Crison J.R., Amidon G.L. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. Int. J. Pharm. 140:1996;111-118.
10. Yu L.X., Lipka E., Crison J.R., Amidon G.L. Transport approaches to the biopharmaceutical design of oral drug delivery systems: Prediction of intestinal absorption. Adv. Drug. Deliv. Rev. 19:1996;359-376.
11. Santella J.P., Tanrisever B. Cefatrizine, a clinical overview. Drugs Exp. Clin. Res. 11:1985;441-446.
12. Pfeffer M., Gaver R.C., Ximenez J. Human intravenous pharmacokinetics and absolute oral bioavailability of cefatrizine. Antimicrob. Agents Chemother. 24:1983;915-920.
13. 14C-cefatrizine in man. Drug Metab. Dispos. 8:1980;157-162.
14. Oberle R.L., Chen T.-S., Lloyd C., Barnett J.L., Owyang C., Meyer J., Amidon G.L. The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids. Gastroenterology. 99:1990;1275-1282.
15. D.Z. D'Argenio, A. Schumitzky, Adapt II: Mathematical Software for Pharmacokinetic/Pharmacodynamic Systems Analysis, University of Southern California, Los Angeles, CA, 1992.
16. Couet W.R., Reigner B.G., Guedes J.-P., Tozer T.N. Theoretical model for both saturable rate and extent of absorption: simulations of cefatrizine data. J. Pharmacokinet Biopharm. 19:1991;271-285.
17. Oberle R.L., Amidon G.L. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; An explanation for the double peak phenomenon. J. Pharmacokinet. Biopharm. 15:1987;529-544.
18. Metcalf A.M., Phillips S.F., Zinsmeister A.R., MacCarty R.L., Beart R.W., Wolff B.G. Simplified assessment of segmental colonic transit. Gastroenterology. 92:1987;40-47.
19. Actor P., Pitkin D.H., Lucyszyn G., Weisbach J.A., Bran J.L. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration - comparative study with cephalexin and cefazolin. Antimicrob. Agents Chemother. 9:1976;800-803.
20. Matsuzaki M., Matsumoto H., Ochiai K., Hirata Y., Hino M. Absorption and excretion of cefatrizine. Jpn. J. Antibiotics. 29:1976;83-89.
21. Mastrandrea V., Ripa S., La-Rosa F., Ghezzi A. Pharmacokinetics of cefatrizine after oral administration in human volunteers. Int. J. Clin. Pharmacol. Res. 5:1985;319-323.
22. Piotrovskij V.K., Kallay Z., Gajdos M., Gerykova M., Trnovec T. The use of a nonlinear absorption model in the study of ascorbic acid bioavailability in man. Biopharm. Drug Dis. 14:1993;429-442.
23. Lennernas H., Ahrenstedt O., Hallgren R., Knutson L., Ryde M., Paalzow L.K. Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm. Res. 9:1992;1243-1251.